NCT03397173: TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
- State
- Completed
- Phase
- Phase 2
- People
- 12 taking part
- Started
- 16 Mar 2018
- Primary completion
- 3 Jan 2021
- Arms
- Azacitidine + Ascorbic acid
- Results
- None posted
- 11 Jan 2018: Trial registered
- 16 Mar 2018: Trial started
- 21 Jan 2021: Trial completed